Hollister, Inc.: FDA filings under this applicant name
FDA lists 100 510(k) clearances under 2 spellings of the applicant name “Hollister, Inc.” (first 1977, latest 2026), across 29 product codes in 6 review panels. Median 510(k) review time under this name: 80 days. Since 2017 the median was 143 days, against 179 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 1 | 128 |
| 2014 | 1 | 64 |
| 2015 | 2 | 26 |
| 2016 | 0 | — |
| 2017 | 1 | 73 |
| 2018 | 2 | 56 |
| 2019 | 2 | 30 |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 3 | 276 |
| 2023 | 0 | — |
| 2024 | 1 | 184 |
| 2025 | 1 | 143 |
| 2026 | 1 | 231 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Hollister, Inc. took a median 143 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 179 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| EXB | Collector, Ostomy | 14 | 14 |
| GBM | Catheter, Urethral | 11 | 11 |
| KPI | Stimulator, Electrical, Non-Implantable, For Incontinence | 10 | 10 |
| ILO | Pack, Hot Or Cold, Water Circulating | 7 | 7 |
| KNT | Tubes, Gastrointestinal (And Accessories) | 7 | 7 |
| FRO | Dressing, Wound, Drug | 6 | 6 |
| EZD | Catheter, Straight | 5 | 5 |
| FMQ | Restraint, Protective | 4 | 4 |
| HIR | Perineometer | 4 | 4 |
| KNX | Collector, Urine, (And Accessories) For Indwelling Catheter | 4 | 4 |
Plus 19 more product codes.
Review panels
- Gastroenterology and Urology (63)
- General and Plastic Surgery (14)
- Physical Medicine (8)
- Obstetrics and Gynecology (7)
- General Hospital (6)
- Orthopedic (1)
Most recent Hollister, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K253295 | Coude Sleeved IC; Coude Plus Sleeved IC | EZD | 2026-05-18 | 231 |
| K251468 | Sleeved IC 3 Family Sleeved IC 3 SWT (name not finalized) Sleeved IC 3 Pocket (name not finalized) Sleeved IC 3 Plus (name not finalized) Sleeved IC 3 Plus Pocket (name not finalized) (N/A) | EZD | 2025-10-03 | 143 |
| K233524 | Sleeved IC 2 Family; Sleeved IC 2 SWT (Name not Finalized); Sleeved IC 2 Plus (Name not Finalized); Sleeved IC 2 Pocket (Name not Finalized); Sleeved IC 2 Plus Pocket (Name not Finalized) | EZD | 2024-05-03 | 184 |
| K220667 | Sleeved IC | EZD | 2022-12-08 | 276 |
| K213575 | Female IC (Not Finalized) | EZD | 2022-09-13 | 307 |
| K211436 | Intermittent Catheter (Not Finalized) | GBM | 2022-01-27 | 262 |
| K193148 | VaPro Plus Pocket, VaPro Plus | GBM | 2019-12-13 | 30 |
| K191633 | Infyna Chic | GBM | 2019-07-19 | 30 |
| K183253 | ValPro 2 Plus, VaPro 2 Plus Pocket | GBM | 2018-12-18 | 27 |
| K180824 | VaPro 2 Intermittent Catheter | GBM | 2018-06-22 | 84 |
90 earlier clearances. See the full list in Caduvo.
Recalls
5 product recalls in 2 recall events; 4 initiated in the last five years. Most recent: 2024-12-23.
3 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Ameda, Inc. (2), Hollister Ulc (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Hollister, Inc. is the lead sponsor of 13 device studies on ClinicalTrials.gov (1 active or recruiting). Most recent:
- NCT07714694: Consumer Evaluation of an Investigational Intermittent Catheter (Completed, started 2026-07-09)
- NCT07460323: Study of TRE Seals on Early Post-operative Subjects (Recruiting, started 2026-06-30)
- NCT06547905: Evaluation of an Ostomy Leakage Detection System (Completed, started 2024-07-24)
- NCT04619992: Consumer Evaluation of Intermittent Catheter Product Modifications (Completed, started 2020-10-14)
- NCT03328182: Assessment of an Oral Endotracheal Subglottic Tube Holder (Completed, started 2017-10-23)
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Hollister, Inc. (a text match, not an official crosswalk):
- L8678 — Electrical stimulator supplies (external) for use with implantable neurostimulator, per month (via KPI)
- C1767 — Generator, neurostimulator (implantable), non-rechargeable (via KPI)
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Hollister, Inc. (85)
- Hollister Incorporated (15)
Frequently asked questions
How many FDA 510(k) clearances are listed under Hollister, Inc.?
FDA lists 100 510(k) clearances under 2 spellings of the applicant name “Hollister, Inc.” (first 1977, latest 2026), across 29 product codes in 6 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Hollister, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Hollister, Inc. is 80 days. Since 2017: 143 days, versus 179 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Hollister, Inc.?
The most frequent FDA product codes under this applicant name are EXB (Collector, Ostomy, 14); GBM (Catheter, Urethral, 11); KPI (Stimulator, Electrical, Non-Implantable, For Incontinence, 10).
Next steps
- See all 100 Hollister, Inc. clearances with predicates and recalls
- Run predicate analysis for product code EXB, Hollister, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.